Related Experiment Video

Updated: Jul 12, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

BRCA1 inhibition of estrogen receptor signaling in transfected cells

S Fan1, J Wang, R Yuan

  • 1Department of Radiation Oncology, Long Island Jewish Medical Center, The Long Island Campus for the Albert Einstein College of Medicine, 270-05 76th Avenue, New Hyde Park, NY 11040, USA.

Science (New York, N.Y.)
|May 21, 1999
PubMed

Insights

Mutations in the BRCA1 gene increase cancer risk. Wild-type BRCA1 may suppress estrogen-driven cell growth, and its loss could contribute to tumor development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Mutations in the breast cancer susceptibility gene BRCA1 are linked to increased risks of breast, ovarian, and prostate cancers.
  • The specific mechanisms underlying this association, particularly concerning the targeted tumor types, remain incompletely understood.

Purpose of the Study:

  • To investigate the functional relationship between BRCA1 and estrogen receptor signaling.
  • To explore the potential role of BRCA1 in suppressing estrogen-dependent pathways involved in mammary epithelial cell proliferation.

Main Methods:

  • Transient transfection assays were employed to assess the interaction between BRCA1 and the estrogen receptor alpha (ER-alpha).
  • The study examined BRCA1's effect on ER-alpha's transcriptional activation function (AF-2) and its interaction with estrogen-responsive enhancer elements.

Main Results:

  • BRCA1 was observed to inhibit signaling mediated by the ligand-activated ER-alpha.
  • BRCA1 effectively blocked the transcriptional activation function AF-2 of ER-alpha.

Conclusions:

  • Wild-type BRCA1 likely functions as a suppressor of estrogen-dependent transcriptional pathways crucial for mammary epithelial cell proliferation.
  • The loss or inactivation of BRCA1's tumor-suppressive function may be a significant factor contributing to tumorigenesis in susceptible tissues.

More Related Videos

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...